Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 June 1998 | Volume 128 Issue 11 | Pages 911-914
Background: In AIDS, nodular skin disease can result from various causes.
Objective: To report a new manifestation of microsporidial infection presenting as nodular skin disease with underlying osteomyelitis.
Design: Case report.
Setting: Tertiary-care military medical center in Washington, D.C.
Patient: A 36-year-old woman with late-stage AIDS who presented with disseminated, nodular cutaneous lesions and underlying osteomyelitis.
Measurements: Disseminated microsporidial infection with an Encephalitozoon-like species was diagnosed by electron microscopic examination of material obtained from the skin lesions.
Intervention: The patient received long-term oral clindamycin therapy, which cured her disseminated infection.
Conclusions: Microsporidia can cause disseminated cutaneous infections in AIDS patients. The response of this patient to long-term clindamycin therapy merits further evaluation.
Within 1 week of stopping clindamycin therapy, the nodules recurred. On re-evaluation, eight painful, erythematous, tender, nodular lesions were found on her lower legs. These lesions were 1.0 cm to 3.0 cm in diameter, and some had dark, necrotic centers (Figure 1). Aspiration of a nodule produced a small amount of purulent material. A Gram stain of this aspirate revealed many neutrophils; monocytes; and large, beaded, gram-positive, bacillary organisms suggestive of mycobacteria (Figure 2, top). Standard cultures for aerobic and anaerobic bacteria, fungi, Bartonella species, and mycobacteria were negative. Treatment with clindamycin was resumed, and the skin lesions resolved gradually. BRIEF COMMUNICATION
Nodular Cutaneous Microsporidiosis in a Patient with AIDS and Successful Treatment with Long-Term Oral Clindamycin Therapy
Microsporidia are ubiquitous, intracellular, protozoal parasites that are commonly associated with veterinary infections [1]. Human microsporidial disease, ranging from specific visceral infections to disseminated disease, has been described in immunocompromised patients [1-4]. More recently, microsporidial disease has been identified in patients with AIDS; it usually presents as enteritis or keratoconjunctivitis. Many of these cases are caused by one of three species: Encephalitozoon hellem, E. intestinalis, or E. bieneusi. Effective therapeutic options for these infections are limited [1]. Although the differential diagnosis for nodular skin lesions in patients with AIDS is extensive, cutaneous microsporidiosis has not been reported until now. We report a case of disseminated, nodular, cutaneous microsporidiosis associated with underlying osteomyelitis that resolved with oral clindamycin therapy in a patient with AIDS.
Case Report
![]()
Top
Case Report
Methods
Results
Discussion
Author & Article Info
References
A 36-year-old woman with AIDS (CD4 cell count, 10 cells/mm3) previously treated for recurrent Pneumocystis carinii pneumonia, disseminated Mycobacterium avium complex infection, bacterial sinusitis, and folliculitis presented with a 1-week history of painful, erythematous, nodular skin lesions on her lower legs. Her sinusitis symptoms had also recurred. Examination revealed three tender, erythematous, scaly, crusted nodules, 0.5 cm to 1.0 cm in diameter. The patient did not have fever. She had minimal bilateral maxillary sinus tenderness and a small amount of purulent rhinorrhea. The patient's medications included clarithromycin, ethambutol, ciprofloxacin, and trimethoprim-sulfamethoxazole. Antiretroviral therapy had been stopped 2 months earlier because of drug intolerance. Because of a ß-lactam allergy, the patient began receiving an empirical 7-day course of oral clindamycin (150 mg every 6 hours) for presumptive bacterial sinusitis and possible furunculosis of the legs. After 1 week of therapy, her sinus symptoms and leg nodules resolved.
|
|
After 1 additional month of therapy, with all skin nodules resolved, clindamycin therapy was discontinued. After 2 weeks, the lesions recurred, and additional nodules appeared on the patient's upper extremities. The patient described worsening pain underlying the affected areas of her lower legs. Another nodule was aspirated, and results of a Gram stain were identical to the previous results. Standard cultures were again done, and results were unrevealing. Multiple blood cultures were negative after prolonged incubation and subculturing. A punch biopsy of a skin nodule showed an intense, dermal, acute, and granulomatous reaction with myriad organisms present. Cultures of the skin biopsy specimen were negative. A bone scan showed several areas of uptake in both legs and arms that were consistent with multifocal osteomyelitis; many of the affected areas of bone were beneath the skin lesions. The patient declined to undergo bone biopsy. Treatment with oral clindamycin was resumed, this time at a higher dosage (300 mg every 6 hours). Clindamycin therapy was continued for 1 year with complete resolution of all skin lesions and bone scan findings. No substantial toxicity was related to the prolonged clindamycin therapy. The patient died 3 years later of other AIDS-related complications with no recurrence of the skin nodules or osteomyelitis.
Methods
|
|---|
|
|
|---|
Results
|
|---|
|
|
|---|
Sections of a punch biopsy specimen taken from a skin nodule and stained with hematoxylin-eosin showed an intense, predominantly histiocytic infiltrate in the lower dermis that extended into the subcutaneous fat. Most of the histiocytes had a foamy appearance, which on high magnification seemed to be caused by rod-shaped organisms. Gram stains of tissue revealed organisms with a mottled gram-positive appearance. These organisms were innumerable, were found free and in phagocytes, were ovoid- to rod-shaped, and ranged from 2 µm to 4 µm in length and 1 µm to 1.5 µm in diameter. A calcofluor white stain showed strong cell-wall fluorescence, implying the presence of chitin.
Transmission electron microscopy of previously Gram-stained material was done approximately 1 year after the patient's initial presentation. The electron µgraphs show organisms that are clearly identifiable as microsporidia. They have a clear exterior space, corresponding with the chitinous coat. The polar tubule is easily identifiable and consists of five to seven single coils (Figure 2, bottom). The precise number of nuclei could not be clearly ascertained. Analysis by PCR was unsuccessful, possibly because of persistence of crystal violet stain in the Gram-stained specimen. Additional paraffin-embedded tissue was not available for PCR.
Discussion
|
|---|
|
|
|---|
Microsporidia are obligate intracellular parasites. Many species have been described by using predominantly morphologic criteria. Four genera (Enterocytozoon, Encephalitozoon, Pleistophora, and Nosema) have been associated with most reported cases of human disease, usually in patients who are substantially immunocompromised. We could not identify the species of the organism that we found, but the morphologic appearance of the coiled polar tubule is most consistent with that of an Encephalitozoon-like species. The taxonomy of microsporidia is in a state of flux, leading to some inconsistencies in speciation. In addition, new genera are being reported to cause human disease; Trachipleistophora hominis, for example, was reported as a cause of myositis in a patient with AIDS [7]. Typical infections associated with AIDS include enteritis and keratitis [1]. Small numbers of disseminated visceral infections have been reported for Encephalitozoon species. None, however, has presented in the manner that we describe [2-4]. In most infections, the host cell for the microsporidian parasite is apparent (such as the enterocyte for E. bieneusi). In this case, the organisms were free in the dermis as well as in macrophages. Given the lack of a clearly defined host cell, it is interesting to speculate whether the macrophages themselves might serve as a host cell, especially given the probable hematogenous dissemination of the infection. Supporting evidence is found in a report of in vitro cultivation of Encephalitozoon intestinalis on monocyte-derived macrophages [8].
The difficulty of diagnosing cutaneous microsporidial infection is highlighted in this case report. The fact that different microsporidial species have variable staining characteristics makes electron microscopy an important diagnostic tool [9]. Such techniques as amplification of DNA or ribosomal RNA by PCR, along with tissue culture or staining with monoclonal antibodies, have been reported to be useful for confirming microsporidial infection [10]. In our case, no residual paraffin-embedded tissue was available for additional studies.
Therapy for microsporidial infections is problematic. The current therapeutic choice for enteritis caused by Encephalitozoon intestinalis is albendazole, but this agent does not provide adequate therapy in some patients [1]. Treatment of infections caused by other microsporidial species remains poorly defined. Although the use of clindamycin in other intracellular parasitic infections (such as toxoplasmosis) has precedent, no data are available on its use for the treatment of any microsporidial infections [11].
This case report highlights a new clinical presentation of a still incompletely understood class of organisms, notable for the diversity of its host species. Our finding of an Encephalitozoon-like species of microsporidia as the cause of disseminated nodular skin disease adds another consideration in the differential diagnosis of this condition in patients with AIDS. The therapeutic response described here strongly suggests a possible role for clindamycin; however, controlled studies, including in vitro susceptibility testing, must be undertaken to better assess the utility of this agent in therapy for microsporidial infections.
Current Mailing Addresses: Dr. Kester: Department of Immunology, Walter Reed Army Institute of Research, Washington, DC 20307-5100.
Dr. Turiansky: Dermatology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001.
Dr. McEvoy: Department of Infectious and Parasitic Diseases Pathology, Armed Forces Institute of Pathology, Washington, DC 20307.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Weber R, Bryan RT, Schwartz DA, Owen RL. Human microsporidial infections. Clin Microbiol Rev. 1994; 7:426-61.
2. Schwartz DA, Bryan RT, Hewan-Lowe KO, Visvesvara GS, Weber R, Cali A, et al. Disseminated microsporidiosis (Encephalitozoon hellem) and acquired immunodeficiency syndrome. Autopsy evidence for respiratory acquisition. Arch Pathol Lab Med. 1992; 116:660-8.
3. Weber R, Kuster H, Visvesvara GS, Bryan RT, Schwartz DA, Luthy R. Disseminated microsporidiosis due to Encephalitozoon hellem: pulmonary colonization, microhematuria, and mild conjunctivitis in a patient with AIDS. Clin Infect Dis. 1993; 17:415-9.
4. Gunnarsson G, Hurlbut D, DeGirolami PC, Federman M, Wanke C. Multiorgan microsporidiosis: report of five cases and review. Clin Infect Dis. 1995; 21:37-44.
5. Ray MC, Gately LE 3d. Dermatologic manifestations of HIV infection and AIDS. Infect Dis Clin North Am. 1994; 8:583-605.
6. Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D.Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev. 1996; 9:435-47.
7. Field AS, Marriott DJ, Milliken ST, Brew BJ, Canning EU, Kench JG, et al. Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS. J Clin Microbiol. 1996; 34:2803-11.
8. Doultree JC, Maerz AL, Ryan NJ, Baird RW, Wright E, Crowe SM, et al. In vitro growth of the microsporidian Septata intestinalis from an AIDS patient with disseminated illness. J Clin Microbiol. 1995; 33:463-70.
9. Shadduck JA. Human microsporidiosis and AIDS. Rev Infect Dis. 1989; 11:203-7.
10. De Groote MA, Visvesvara G, Wilson ML, Pieniazek NJ, Slemenda SB, daSilva AJ, et al. Polymerase chain reaction and culture confirmation of disseminated Encephalitozoon cuniculi in a patient with AIDS: successful therapy with albendazole. J Infect Dis. 1995; 171:1375-8.[Medline]
11. Dannemann B, McCutchan A, israelski D, Antoniskis D, Leport C, Luft B, et al. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann Intern Med. 1992; 116:33-43.
This article has been cited by other articles:
![]() |
T. K. Graczyk, M. A. Johansson, L. Tamang, G. S. Visvesvara, L. S. Moura, A. J. DaSilva, A. S. Girouard, and O. Matos Retrospective Species Identification of Microsporidian Spores in Diarrheic Fecal Samples from Human Immunodeficiency Virus/AIDS Patients by Multiplexed Fluorescence In Situ Hybridization J. Clin. Microbiol., April 1, 2007; 45(4): 1255 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Kester, G. S. Visvesara, and P. McEvoy Organism Responsible for Nodular Cutaneous Microsporidiosis in a Patient with AIDS Ann Intern Med, December 5, 2000; 133(11): 925 - 925. [Full Text] [PDF] |
||||
![]() |
K. Wasson and R. L. Peper Mammalian Microsporidiosis Vet. Pathol., March 1, 2000; 37(2): 113 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Franzen and A. Muller Molecular Techniques for Detection, Species Differentiation, and Phylogenetic Analysis of Microsporidia Clin. Microbiol. Rev., April 1, 1999; 12(2): 243 - 285. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||